Chronotropic Incompetence Could Serve as a Prognostic Biomarker in ATTR-CM Rare Disease Advisor 00:14
HELIOS-B Trial Finds No Sex-Based Differences in Vutrisiran Efficacy for ATTR-CM Rare Disease Advisor 01:08 Mon, 27 Jul
Early Access Tafamidis Linked With Symptom Stability in ATTR-CM Rare Disease Advisor 01:19 Wed, 22 Jul
Mineralocorticoid Receptor Antagonists Do Not Seem Beneficial in ATTR-CM Rare Disease Advisor 01:42 Tue, 21 Jul
Atrial Fibrillation Status Is Associated With Ventilatory Efficacy in ATTR-CM Rare Disease Advisor 01:12 Tue, 21 Jul
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial The Cardiology Advisor 15:42 Wed, 15 Jul
Early Scintigraphy Streamlines ATTR-CM Diagnosis With Comparable Accuracy Rare Disease Advisor 00:10 Wed, 15 Jul
Push for Cath Lab Safety; Eplontersen Flops in ATTR-CM; Off-Label Testosterone Risks Medpage Today 18:59 Tue, 14 Jul
Patients With ATTR-CM Should Be Neurologically Assessed, Study Says Rare Disease Advisor 00:23 Tue, 14 Jul
AstraZeneca and Ionis’ stocks drop significantly on Wainua ATTR-CM trial failure Clinical Trials Arena 10:20 Fri, 10 Jul
Ionis and AstraZeneca: Shares Tank as Phase 3 ATTR-CM Trial Falls Short of Expectations MorningStar.com 09:48 Fri, 10 Jul
AstraZeneca’s Trial-Design Halo Slips As Wainua Fails Phase III In ATTR-CM Scrip Pharma Intelligence 11:17 Thu, 09 Jul
Ionis And AstraZeneca's Cardio-TTRansform Trial Of Eplontersen In Attr-Cm Misses Primary Endpoint RTT News 09:45 Thu, 09 Jul
Echocardiographic Score Shows High Diagnostic Performance for ATTR-CM Rare Disease Advisor 00:49 Wed, 08 Jul
New Mathematical Model Could Help Select Best Treatment for Patients With ATTR-CM Rare Disease Advisor 00:39 Wed, 08 Jul
